When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

   www.aol.com/fda-approves-biosimilars-macular...

   Macular degeneration treatment is safe and effective. ... biosimilars can sometimes offer a more affordable — but similarly safe and effective — alternative to an existing medication.

3. Gene therapy of the human retina - Wikipedia

   en.wikipedia.org/wiki/Gene_therapy_of_the_human...

   Following the successful clinical trials in LCA, researchers have been developing similar treatments using adeno-associated virus for age-related macular degeneration (AMD). To date, efforts have focused on long-term delivery of VEGF inhibitors to treat the wet form of macular degeneration. Whereas wet AMD is currently treated using frequent ...

4. Stem cell therapy for macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Stem_cell_therapy_for...

   Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]

5. Anti-VEGF - Wikipedia

   en.wikipedia.org/wiki/Anti-VEGF

   This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab , antibody derivatives such as ranibizumab (Lucentis), or orally-available small molecules that inhibit the tyrosine kinases stimulated by VEGF: sunitinib , sorafenib , axitinib , and pazopanib ...

6. Astellas Institute for Regenerative Medicine - Wikipedia

   en.wikipedia.org/wiki/Astellas_Institute_for...

   Astellas Institute for Regenerative Medicine; Company type: Subsidiary: Industry: Biotechnology: Founded: 1994: Headquarters: Marlborough, MA: Products: Stem cell therapies for macular degeneration (human safety trial started in 2010 [1]), retinis pigmentosa, glaucoma and corneal blindness [2]

7. Regenerative medicine - Wikipedia

   en.wikipedia.org/wiki/Regenerative_medicine

   On September 12, 2014, surgeons at the Institute of Biomedical Research and Innovation Hospital in Kobe, Japan, transplanted a 1.3 by 3.0 millimeter sheet of retinal pigment epithelium cells, which were differentiated from iPS cells through directed differentiation, into an eye of an elderly woman, who suffers from age-related macular degeneration.